Vera Therapeutics Inc Class A (VERA)
R&D Expenses
$60.08M
Quarterly · Period ending: · USD
VERA R&D Expenses
Latest reported$60.08Mperiod ending
Latest reported$60.08Mperiod ending
VERA Quarterly R&D Expenses ($1.44M → $60.08M)
Quarterly R&D Expenses
High-resolution chart · PNG
VERA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 60,080,000 | |
| 86,011,000 | |
| 59,310,000 | |
| 56,473,000 | |
| 58,195,000 | |
| 41,278,000 | |
| 33,347,000 | |
| 40,314,000 | |
| 29,311,000 | |
| 24,669,000 | |
| 21,952,000 | |
| 16,100,000 | |
| 16,231,000 | |
| 25,614,000 | |
| 26,676,000 | |
| 19,656,000 | |
| 10,112,000 | |
| 12,549,000 | |
| 12,753,000 | |
| 3,564,000 | |
| 3,235,000 | |
| 2,932,000 | |
| 39,844,000 | |
| 1,969,000 | |
| 1,954,000 | |
| 1,439,000 |